Zevaquenabant, CAS [[1998760-00-1]]
Artikelnummer:
MCE-HY-141411A
| Artikelname: |
Zevaquenabant, CAS [[1998760-00-1]] |
| Artikelnummer: |
MCE-HY-141411A |
| Hersteller Artikelnummer: |
HY-141411A |
| Alternativnummer: |
MCE-HY-141411A-50MG,MCE-HY-141411A-10MMX1ML,MCE-HY-141411A-25MG,MCE-HY-141411A-10MG,MCE-HY-141411A-5MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| Alternative Synonym: |
(S)-MRI-1867 |
| Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual cannabinoid CB1 receptor and inducible NOS antagonist. Zevaquenabant ameliorates obesity-induced chronic kidney disease (CKD)[1]. |
| Molekulargewicht: |
547.98 |
| Reinheit: |
99.64 |
| CAS Nummer: |
[1998760-00-1] |
| Formel: |
C25H21ClF3N5O2S |
| Target-Kategorie: |
Cannabinoid Receptor,NO Synthase |
| Anwendungsbeschreibung: |
MCE Product type: Reference compound |
